Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01910831 · ClinicalTrials.gov registry record · Phase 4
Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms and Hands
A Phase 4 study, sponsored by The Center for Clinical and Cosmetic Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01910831 is a Phase 4 study that has completed, run by The Center for Clinical and Cosmetic Research. The registered enrollment target is 20 participants.
The verdict
NCT01910831, a Phase 4 study, has completed, sponsored by The Center for Clinical and Cosmetic Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine the efficacy (measured at 12 weeks) of DerMend Moisturizing Bruise Formula in improving the appearance of bruising and reducing the appearance of photoaging of the forearms and hands in mature skin. Assessments will be made through ongoing objective measurements and clinical ratings. To confirm the safety (local tolerance) of DerMend Moisturizing Bruise Formula.
Interventions
- DRUG DerMend Moisturizing Bruise Formula
- DRUG Non-active placebo control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01910831
The ClinicalTrials.gov registry entry for NCT01910831 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Center for Clinical and Cosmetic Research, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DerMend Moisturizing Bruise Formula is the first listed.
NCT01910831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01910831 about?
NCT01910831 is a clinical study titled "Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms and Hands". To determine the efficacy (measured at 12 weeks) of DerMend Moisturizing Bruise Formula in improving the appearance of bruising and reducing the appearance of photoaging of the forearms and hands in mature skin. Assessments will be made through ongoing objective measurements and clinical ratings. T...
What is the current status of trial NCT01910831?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2013-07. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01910831?
The interventions under investigation include: DerMend Moisturizing Bruise Formula (DRUG), Non-active placebo control (DRUG).
Who is sponsoring clinical trial NCT01910831?
This trial is sponsored by The Center for Clinical and Cosmetic Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.